Stella Pharma Corporation (4888.T)

JPY 555.0

(0.18%)

Annual Balance Sheets

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Total Assets 3.82 Billion 4.32 Billion 4.71 Billion 2.04 Billion 2.66 Billion
Total Current Assets 3.62 Billion 3.79 Billion 4.17 Billion 1.81 Billion 2.4 Billion
Cash And Short Term Investments 2.35 Billion 2.71 Billion 3.27 Billion 1.25 Billion 2 Billion
Cash and Cash Equivalents 2.05 Billion 2.71 Billion 3.27 Billion 1.25 Billion 2 Billion
Short Term Investments 300.94 Million -68.25 Million -77.46 Million - -
Net Receivables 116.86 Million 98.77 Million 53.38 Million 95.98 Million 41.44 Million
Inventory 1.11 Billion 940.59 Million 773.62 Million 392.88 Million 305.75 Million
Other Current Assets 42.52 Million 43.06 Million 71.98 Million 70.72 Million 46.81 Million
Total Non-Current Assets 191.32 Million 536.31 Million 543.46 Million 237.65 Million 258.96 Million
Net PPE 81.52 Million 102.87 Million 92.02 Million 68.48 Million 68.16 Million
Good Will And Intangible Assets 52.54 Million 61.66 Million 68.44 Million 79.66 Million 90 Million
Good Will - - - - -
Intangible Assets 52.54 Million 61.66 Million 68.44 Million 79.66 Million 90 Million
Long-Term Investments 57 Million 371 Million 382 Million 89 Million 100 Million
Tax Assets -57 Million -371 Million -382 Million -89 Million -99.9 Million
Other Non Current Assets 57.25 Million 371.77 Million 382.99 Million 89.51 Million 100.7 Million
Other Assets 2000.00 3000.00 1000.00 1000.00 1.00
Total Liabilities 1.44 Billion 1.57 Billion 1.63 Billion 1.81 Billion 1.96 Billion
Total Current Liabilities 455.59 Million 421.58 Million 308.08 Million 319.11 Million 307.5 Million
Account Payables 75.69 Million 49.06 Million 48.59 Million 61.82 Million 23.8 Million
Tax Payables 9.98 Million 6.33 Million 28.12 Million 6.72 Million 6.68 Million
Short Term Debt 160 Million 160 Million 160 Million 160 Million 160 Million
Deferred Revenue 217.11 Million 208.48 Million 94.49 Million 93.22 Million 6.68 Million
Other Current Liabilities 2.78 Million 4.02 Million 4.99 Million 4.06 Million 117 Million
Total Non Current Liabilities 988.01 Million 1.15 Billion 1.33 Billion 1.49 Billion 1.66 Billion
Long-Term Debt 773.29 Million 933.3 Million 1.09 Billion 1.25 Billion 1.41 Billion
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 214.71 Million 221.66 Million 237.63 Million 245.37 Million 249.14 Million
Other Liabilities - - - - -
Total Equity 2.37 Billion 2.75 Billion 3.07 Billion 230.71 Million 690.03 Million
Stock Holders Equity 2.37 Billion 2.75 Billion 3.07 Billion 230.71 Million 690.03 Million
Common Stock 2.93 Billion 3.3 Billion 3.8 Billion 1.99 Billion 1.9 Billion
Retained Earnings -763.74 Million -778.82 Million -2.63 Billion -1.86 Billion -1.2 Billion
Accumulated other comprehensive income 6 Million 10 Million -1 Million 1 Million -1 Million
Common Stock Equity 2.37 Billion 2.75 Billion 3.07 Billion 230.71 Million 690.03 Million
Capital Lease Obligation - - - - -
Total Investments 300.94 Million 302.74 Million 304.53 Million 89 Million 100 Million
Total Debt 933.3 Million 1.09 Billion 1.25 Billion 1.41 Billion 1.57 Billion
Net Debt -1.11 Billion -1.61 Billion -2.02 Billion 162.04 Million -433.69 Million

Balance Sheet Charts